Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Translational Platform for Polyimide Neural Interfaces: Polyimide Synthesis and in Vivo Evaluation in Epileptic Mice.

IEEE access : practical innovations, open solutions·2026
Same author

Hydrogen Sulfide-Releasing Insulin Polypeptide Mitigates Hyperglycemia-Induced Neurotoxicity and Cognitive Deficits <i>In Vivo</i>.

ACS chemical neuroscience·2025
Same author

Inactivation of Laforin Phosphatase and Increased Glucose Uptake Underlie Glycogen Synthase-Mediated Neuronal Survival Under Oxidative Stress.

Molecular neurobiology·2025
Same author

Glycogen synthase is required for heat shock-mediated autophagy induction in neuronal cells.

Biology open·2025
Same author

Neuromuscular junction dysfunction in Lafora disease.

Disease models & mechanisms·2024
Same author

Synthesis of a highly thermostable insulin by phenylalanine conjugation at B29 Lysine.

Communications chemistry·2024

Related Experiment Video

Updated: May 25, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Autophagy defects in Lafora disease: cause or consequence?

Rajat Puri1, Subramaniam Ganesh

  • 1Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India.

Autophagy
|February 4, 2012
PubMed
Summary

Lafora disease (LD) involves abnormal glycogen (Lafora bodies) in neurons. Our study shows these bodies impair cellular waste removal pathways, contributing to neurodegeneration.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Lafora disease (LD) is a fatal, inherited neurodegenerative disorder.
  • Characterized by Lafora bodies (abnormal glycogen inclusions) in neurons and other tissues.
  • The precise mechanism by which Lafora bodies cause neuronal dysfunction remains unclear.

Purpose of the Study:

  • To investigate the functional impact of Lafora bodies on neuronal pathways.
  • To elucidate the neuropathological mechanisms contributing to Lafora disease progression.

Main Methods:

  • Utilized a Lafora disease animal model.
  • Examined the integrity and function of endosomal-lysosomal and autophagy pathways.
  • Assessed the relationship between Lafora body accumulation and pathway impairment.

More Related Videos

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
06:58

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
06:58

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles

Published on: October 18, 2024

Main Results:

  • Demonstrated that Lafora bodies are associated with impaired endosomal-lysosomal function.
  • Showed a significant disruption in autophagy pathways in the presence of Lafora bodies.
  • Provided evidence linking Lafora body accumulation to cellular dysfunction.

Conclusions:

  • Lafora bodies may contribute to neuronal dysfunction by disrupting essential cellular clearance mechanisms.
  • Impairment of the endosomal-lysosomal and autophagy pathways is a key neuropathological feature in Lafora disease.
  • Findings offer insights into potential therapeutic targets for Lafora disease.